4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cellyan Biotechnology Co., Ltd (HKPD) operates in the Medical Distribution industry and is headquartered in Yau Tong, Hong Kong with about 27 employees. Its market capitalization is roughly $11 million. In the fiscal year ended 2025-03-31, HKPD reported $20M in revenue and $0M in net income.
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Interactive charts & full statements → Open the HKPD valuation workbench →
| Income statement | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Total Revenue | $20M | $17M | $13M |
| Gross Profit | $2M | $4M | $3M |
| Operating Income (EBIT) | $0M | $2M | $1M |
| Net Income | $0M | $1M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Total Assets | $9M | $9M | $3M |
| Total Liabilities | $4M | $4M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HKPD viewer.
About TickerBase · Data methodology & sources